Advertisement
U.S. Markets closed

Allergy Therapeutics plc (AGY.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
4.8800-0.1200 (-2.40%)
At close: 04:35PM BST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
53,258
59,587
72,768
84,331
78,204
Cost of Revenue
25,276
26,342
23,262
22,106
20,201
Gross Profit
27,982
33,245
49,506
62,225
58,003
Operating Expense
66,819
68,149
61,751
58,194
49,694
Operating Income
-38,837
-34,904
-12,245
4,031
8,309
Net Non Operating Interest Income Expense
-4,899
-2,112
-412
-374
-238
Pretax Income
-48,482
-41,766
-12,657
3,657
8,071
Tax Provision
1,734
1,305
1,119
771
1,013
Net Income Common Stockholders
-50,216
-43,071
-13,776
2,886
7,058
Diluted NI Available to Com Stockholders
-50,216
-43,071
-13,776
2,886
7,058
Basic EPS
-0.01
-0.08
-0.02
0.00
0.01
Diluted EPS
-0.01
-0.08
-0.02
0.00
0.01
Basic Average Shares
641,444
670,355
642,990
639,190
636,169
Diluted Average Shares
679,050
670,355
684,076
676,658
673,492
Total Operating Income as Reported
-43,583
-39,654
-12,245
4,031
8,309
Rent Expense Supplemental
0
-
-
-
0
Total Expenses
92,095
94,491
85,013
80,300
69,895
Net Income from Continuing & Discontinued Operation
-50,216
-43,071
-13,776
2,886
7,058
Normalized Income
-46,372
-39,223
-13,776
2,886
7,058
Interest Income
333
329
254
107
261
Interest Expense
5,232
2,441
669
491
504
Net Interest Income
-4,899
-2,112
-412
-374
-238
EBIT
-43,250
-39,325
-11,988
4,148
8,575
EBITDA
-39,014
-35,101
-7,822
8,280
12,489
Reconciled Cost of Revenue
25,276
26,342
23,262
22,106
20,201
Reconciled Depreciation
4,236
4,224
4,166
4,132
3,914
Net Income from Continuing Operation Net Minority Interest
-50,216
-43,071
-13,776
2,886
7,058
Total Unusual Items Excluding Goodwill
-4,746
-4,750
0
-
-
Total Unusual Items
-4,746
-4,750
0
-
-
Normalized EBITDA
-34,268
-30,351
-7,822
8,280
12,489
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-901.74
-902.5
0
0
0